The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...

The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

Paired with an existing test, this could become a life-saving diagnostic tool for people with a notoriously deadly form of ...

A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...

Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...